Private equity continues to drive the majority of home-based care M&A activity in 2026. Understanding who the active buyers are — and what each one is looking for — is one of the most useful pieces of context an agency owner can have when evaluating a sale.
This guide is a practical overview of the most active PE participants in home-based care, organized by segment focus. Activity in this space is heavily concentrated through PE-backed portfolio platforms making add-on acquisitions, rather than direct sponsor acquisitions of individual agencies. We have included both layers.
A note on scope: the firms below are active acquirers as of early 2026. Deal activity, fund cycles, and platform strategies shift regularly. Any sale process should be informed by current intelligence on which platforms are buying, in which geographies, at what scale, and at what valuations — not on a static list.
Three layers matter when thinking about PE in home-based care:
When an agency owner gets approached by a “PE buyer,” it is almost always one of the platform companies, not the sponsor directly. The sponsor sets strategy and funding capacity; the platform does the acquiring.
The non-medical home care segment has seen the most consolidation of any home-based care vertical. Active platforms include:
What they look for: defensible local market position, $500K+ EBITDA, scalable referral sources, clean operations, and geographic fit with existing density.
Medicare home health consolidation is dominated by a smaller number of large platforms:
What they look for: strong star ratings, low LUPA rates, deficiency-free survey history, geographic fit, $1M+ EBITDA, and CON state positioning where applicable.
Hospice has been one of the most active M&A segments of the past five years. Active acquirers include:
What they look for: average daily census growth trajectory, Medicare cap headroom, diversified referral sources, clean OIG/SFP profile, geographic density, and $750K+ EBITDA for add-ons.
Pediatric is a smaller universe of active acquirers, with a few dominant platforms:
What they look for: pediatric-specific clinical capability (vent/trach, complex care), nurse retention infrastructure, authorized-hours fill rate, payer rate strength, and geographic concentration.
Behavioral health and ABA M&A have their own ecosystem, with significant PE activity:
What they look for: clinical model integrity, payer mix (commercial and Medicaid), staff retention, BCBA capacity in ABA, and geographic fit.
Intellectual and developmental disability service providers have a distinct buyer set:
What they look for: state-by-state regulatory positioning, residential and day program licensing, workforce stability, and Medicaid waiver contract relationships.
Knowing the active buyer set is useful for several reasons:
A well-run sale process targets a curated list of buyers most likely to value your specific business — not a mass-marketed auction. The right buyer for your agency depends on your segment, scale, geography, and operational profile.
Each platform has a specific acquisition thesis: geographic expansion in certain states, service line additions, payer mix diversification, or scale build in a particular vertical. Agencies that fit the active thesis of multiple platforms attract competitive offers. Agencies that fit no current thesis sell harder, even when they are well-run.
Many agency owners receive direct outreach from PE platforms or business development teams. These outreach conversations are part of the platform’s deal sourcing — they are not yet offers. Engaging with them outside of a structured advisor-led process typically produces lower outcomes than running a competitive process with multiple buyers.
Multiples reported in industry press are usually for the largest, most strategic transactions — not a representative sample. Understanding which buyers are paying which multiples, for which kinds of agencies, in which geographies, is the only way to anchor your own valuation expectations realistically.
Which buyers are buying right now. Platforms move in and out of acquisition mode based on integration capacity, fund timing, and strategic priorities. A platform that was the most active buyer in your segment 18 months ago may be in integration mode now.
Which buyers will pay the highest multiple for your specific agency. That depends on geographic fit, service line fit, scale, payer mix, and the platform’s current strategic gaps.
What current actual deal terms look like. Multiples, structure (cash vs. rollover vs. earnout), and reps and warranties packages move with market conditions.
A sale process built on current intelligence — which platforms are actively buying, where, at what scale, and at what current terms — is materially different from one built on a static buyer list.
The PE buyer landscape in home-based care is concentrated, sophisticated, and well-capitalized. For agency owners evaluating a sale, the practical implications are:
If you would like to understand which active buyers are most likely to value your specific agency, contact us for a confidential conversation.
Private Equity Firms Buying Home Care in 2026: Profiles, Check Sizes, and What Each Wants
Market UpdatesQ2 2026 Home-Based Care M&A Report: Transactions, Multiples, and Buyer Trends
State GuidesSelling a Home Care Agency in Colorado: 2026 Market Guide
State GuidesSelling a Home Care Agency in Illinois: 2026 Market Guide
State GuidesSelling a Home Care Agency in Massachusetts: 2026 Market Guide
State GuidesSelling a Home Care Agency in Pennsylvania: 2026 Market Guide
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.